The increase in angiogenic ECs in AAA from Prdx2−/− mice infused with Ang II was confirmed by immunostaining for CD31 in aneurysmal lesions (Fig. 4d) and by immunoblotting of VEGFR2 in aneurysmal aortas (Fig. 4f). This evidence concerns the gene KDR and triple-A syndrome.